The third round of Seed Funding opened for competitive applications on 15 May 2019 and closed on 15 August 2019.  A total of 24 applications were received, they were reviewed by the working group on 4 September 2019.  The working group recommended that seven applications be funded, and this was ratified by the Board at their meeting on 26 September 2019.

Total grant funding awarded in Round 3 Seed Funding was $636,690.50.

Co-design of clinical alerts as part of a drug early warning network in Victoria, Australia

Amount Awarded: $95,481.00

Principal Investigator: Dr Monica Barratt, Royal Melbourne Institute of Technology (RMIT).

Determining the feasibility and efficacy of Goal Management Training for improving treatment retention and outcomes during residential treatment for methamphetamine dependence

Amount Awarded: $94,369.00

Principal Investigator: Prof Antonio Verdejo-Garcia, Monash University

BeSMART: feasibility and preliminary efficacy of an intervention for family members impacted by methamphetamine

Amount awarded: $61,342.00

Principal Investigator: A/Prof Peter Kelly, University of Wollongong.

Understanding emerging opioid-related harms through improved surveillance, drug checking and information sharing systems

Amount awarded: $98,774.00

Principal Investigator: A/Prof Suzanne Nielsen, Monash University

An open label pilot study of intranasal oxytocin for methamphetamine withdrawal in women

Amount awarded: $95,604.50

Principal Investigator: Dr Shalini Arunogiri, Eastern Health.

Risk communication for people who use illicit drugs: establishing guidance on consumer preferences and behavioural responses to drug alerts

Amount Awarded: $96,120.00

Principal Investigator: Dr Amy Peacock, University of New South Wales